Benzimidazole derivatives as EP4 ligands

US10730856B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Olaf Peters · Bad Tabarz, DE
• Nico Bräuer · Falkensee, DE
• Ulrich Bothe · Berlin, DE
• Marcus Koppitz · Berlin, DE
• Jens Nagel · Daxweiler, DE
• Gernot Langer · Falkensee, DE

Key dates

• Filing date: Dec 16, 2014
• Grant date: Aug 4, 2020
• Expiry date: Dec 16, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel benzimidazole derivatives of the general formula (I), to processes for their preparation and to their use for preparing pharmaceutical compositions for the treatment of disorders and indications associated with the EP4 receptor.